These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 17409422)

  • 1. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells.
    Rhim JS; Li H; Furusato B
    Adv Exp Med Biol; 2011; 720():71-80. PubMed ID: 21901619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel human cancer culture model for the study of prostate cancer.
    Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
    Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
    Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
    Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.
    Gu G; Yuan J; Wills M; Kasper S
    Cancer Res; 2007 May; 67(10):4807-15. PubMed ID: 17510410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
    Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
    Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
    Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
    Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
    Gu Y; Kim KH; Ko D; Srivastava S; Moul JW; McLeod DG; Rhim JS
    Anticancer Res; 2005; 25(1A):1-8. PubMed ID: 15816512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective identification of tumorigenic prostate cancer stem cells.
    Collins AT; Berry PA; Hyde C; Stower MJ; Maitland NJ
    Cancer Res; 2005 Dec; 65(23):10946-51. PubMed ID: 16322242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
    Kim KH; Dobi A; Shaheduzzaman S; Gao CL; Masuda K; Li H; Drukier A; Gu Y; Srikantan V; Rhim JS; Srivastava S
    Prostate Cancer Prostatic Dis; 2007; 10(1):30-8. PubMed ID: 17075604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.
    Moriyama T; Ohuchida K; Mizumoto K; Cui L; Ikenaga N; Sato N; Tanaka M
    Cancer; 2010 Jul; 116(14):3357-68. PubMed ID: 20564084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
    Goodyear SM; Amatangelo MD; Stearns ME
    Prostate; 2009 May; 69(7):689-98. PubMed ID: 19143028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.
    Cioffi M; D'Alterio C; Camerlingo R; Tirino V; Consales C; Riccio A; Ieranò C; Cecere SC; Losito NS; Greggi S; Pignata S; Pirozzi G; Scala S
    Sci Rep; 2015 May; 5():10357. PubMed ID: 26020117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.